Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities

Nephrol Dial Transplant. 2012 Oct;27(10):3899-907. doi: 10.1093/ndt/gfs329. Epub 2012 Aug 3.

Abstract

Background: To obtain a clear understanding of the pathogenesis of lipoprotein glomerulopathy (LPG), we studied the role of the deficiency of Fc receptor gamma chain (FcRγ) for the development of LPG in concert with apolipoprotein E (apoE) abnormalities.

Methods: We generated apoE and FcRγ double-knockout (FcRγ/apoE-KO) mice, and subsequently introduced several kinds of human recombinant apoE genes. At 21 days after infection, the mice were sacrificed and histologically examined. Peritoneal macrophages were evaluated for their response to modified lipids.

Results: In the FcRγ/apoE-KO mice, the human apoE3-injected mice showed the most drastic LPG-like changes, as well as prominent hypertriglyceridemia. Meanwhile, relative to the human apoE3-injected mice, the FcRγ/apoE-KO mice showed greater lipoprotein deposition and less macrophage infiltration into the mesangial area. Moreover, the peritoneal macrophages in the apoE/FcRγ-KO mice were impaired in lipid uptake and secretion of the cytokines monocyte chemotactic protein-1 and regulated upon activation, normal T-cell expressed and secreted, after the uptake of oxidized low-density lipoprotein.

Conclusions: These results suggest that the impairment of macrophage function resulting from FcRγ deficiency plays a principal role in the development of LPG in the presence of apoE abnormalities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoprotein E3 / blood
  • Apolipoprotein E3 / genetics
  • Apolipoprotein E3 / metabolism
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics
  • Apolipoproteins E / metabolism*
  • Humans
  • Kidney Diseases / etiology*
  • Kidney Diseases / metabolism
  • Kidney Diseases / pathology
  • Kidney Glomerulus / metabolism
  • Kidney Glomerulus / pathology
  • Lipids / blood
  • Lipoproteins, LDL / metabolism
  • Lipoproteins, LDL / pharmacology
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism*
  • Macrophages, Peritoneal / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Receptors, IgG / deficiency*
  • Receptors, IgG / genetics
  • Receptors, IgG / metabolism
  • Recombinant Proteins / blood
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism

Substances

  • Apolipoprotein E3
  • Apolipoproteins E
  • Lipids
  • Lipoproteins, LDL
  • Receptors, IgG
  • Recombinant Proteins
  • oxidized low density lipoprotein

Supplementary concepts

  • Lipoprotein Glomerulopathy